NYSE:INO
Inovio Pharmaceuticals Stock News
$11.88
-0.220 (-1.82%)
At Close: May 06, 2024
1 Beaten-Down Growth Stock To Avoid Like the Plague
11:40am, Sunday, 24'th Jul 2022 The Motley Fool
The last few years haven't been kind to Inovio Pharmaceuticals.
1 Beaten-Down Growth Stock To Avoid Like the Plague
07:40am, Sunday, 24'th Jul 2022
The last few years haven't been kind to Inovio Pharmaceuticals.
After Slashing Costs, Is Inovio a Buy?
10:30am, Friday, 22'nd Jul 2022 The Motley Fool
It's betting on success as a vaccine latecomer.
After Slashing Costs, Is Inovio a Buy?
06:30am, Friday, 22'nd Jul 2022
It's betting on success as a vaccine latecomer.
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
08:40am, Thursday, 21'st Jul 2022 Benzinga
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Direct Digital Ho
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
04:50pm, Wednesday, 20'th Jul 2022 Benzinga
Gainers
Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year gr
RBC Capital Lowers Inovio Price Target As It Awaits This
07:14pm, Tuesday, 19'th Jul 2022 Benzinga
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ: INO) to $4 from $5 with a Sector Perform rating.
The analysts updated the model to reflect the evolution of
RBC Capital Lowers Inovio Price Target As It Awaits This
03:22pm, Tuesday, 19'th Jul 2022
RBC Capital Markets has lowered the price target on Inovio Pharmaceuticals Inc (NASDAQ: INO) to $4 from $5 with a Sector Perform rating. The analysts updated the model to reflect the evolution of
Inovio to reduce its workforce by 18%
08:21am, Tuesday, 19'th Jul 2022
Inovio Pharmaceuticals Inc. INO, -6.60% said Tuesday that it plans to reduce its full-time workforce by 18% and its contractor workforce by 86% in an effort to extend its cash runway. The company had
Why Inovio Pharmaceuticals Stock Topped the Market on Monday
11:10pm, Monday, 27'th Jun 2022 The Motley Fool
The appointment of a new top executive clearly meets with investor approval.
Why Inovio Pharmaceuticals Stock Topped the Market on Monday
07:10pm, Monday, 27'th Jun 2022
The appointment of a new top executive clearly meets with investor approval.
7 Monkeypox Stocks That May Take Off in Q2
06:28am, Thursday, 09'th Jun 2022
SIGA Technologies (SIGA) may lead on the list of monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race. The post 7 Monkeypox Stocks That May Take Off in Q2 appeared
Inovio Pharmaceuticals, Inc. (INO) CEO Jacqui Shea Present at Jefferies 2022 Global Healthcare Conference (Transcript)
03:55pm, Wednesday, 08'th Jun 2022
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Jefferies 2022 Global Healthcare Conference June 8, 2022 1:00 PM ET Company Participants Jacqui Shea - CEO Jeffrey Skolnik - CMO Conference Call Participants
Stock Market Plunge: 2 Stocks to Avoid Right Now
12:45pm, Thursday, 02'nd Jun 2022 The Motley Fool
Prudent investors should look elsewhere.
Monkeypox cases drove up stock prices for these companies on Monday
12:45pm, Saturday, 28'th May 2022 MarketWatch
This includes GeoVax Labs and Emergent Biosolutions.
